Study Title: Adbelimumab Combined With Chemotherapy and Apatinib in Patients With Resectable Esophageal Squamous Cell Carcinoma
Inclusion/Exclusion Criteria:
Description

Inclusion Criteria:
Signed informed consent.
Patients age 18 to 75 years old.
Primary resectable, histologically confirmed esophageal squamous cell cancer.
Esophageal squamous cell carcinoma the clinical stage was II-IVA (according to AJCC TNM stage, 8th edition).
ECOG PS 0-1.
No distant metastasis, the diseases could be resectable assessed by thoracic oncologist.


Exclusion Criteria:
With significant cardiovascular disease.
Current treatment with anti-viral therapy or HBV.
Female patients who are pregnant or lactating.
History of malignancy within 5 years prior to screening.
Active or history of autoimmune disease or immune deficiency.
Signs of distant metastases.


Other Criteria:
Ages Eligible for Study
18 Years to 75 Years (Adult,  Older Adult )
Sexes Eligible for Study
All
Accepts Healthy Volunteers
No